Biomolecules & Therapeutics : eISSN 1976-9148 / pISSN 2005-4483

Cited by CrossRef (7)

  1. Min Woo Kim, Wenjing Wang, Mateo I Sanchez, Robert Coukos, Mark von Zastrow, Alice Y Ting. Time-gated detection of protein-protein interactions with transcriptional readout. 2017;6
  2. Mohammad M. Ahmadzai, David Broadbent, Christopher Occhiuto, Canchai Yang, Rupali Das, Hariharan Subramanian. G Protein-Coupled Receptors in Immune Response and Regulation. 2017.
  3. Abraham Madariaga-Mazón, Andrés F. Marmolejo-Valencia, Yangmei Li, Lawrence Toll, Richard A. Houghten, Karina Martinez-Mayorga. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?. Drug Discovery Today 2017;22:1719
  4. Kyeong-Man Kim. Conceptual Progress for the Improvements in the Selectivity and Efficacy of G Protein-Coupled Receptor Therapeutics: An Overview. Biomolecules & Therapeutics 2017;25:1
  5. Leif Hertz, Ye Chen. Glycogenolysis, an astrocyte-specific reaction, is essential for both astrocytic and neuronal activities involved in learning. Neuroscience 2017
  6. Thomas M. Tzschentke, Babette Y. Kögel, Stefanie Frosch, Klaus Linz. Limited potential of cebranopadol to produce opioid-type physical dependence in rodents. Addiction Biology 2017
  7. Thomas M. Tzschentke, Kris Rutten. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat. Neuropharmacology 2018;129:100